Advantar Labs moving to new site to build CRO relationships

- Last updated on GMT

Advantar Labs moving to new site to build CRO relationships

Related tags: Service provider, Service

Advantar Laboratories is moving to a bigger facility in San Diego this week to expand its relationships with CROs.

The analytical development and formulation service provider will use the bigger facility, which covers 18,000 square foot in California, to develop its business with CROs (contract research organisations).

The larger facility will also allow for the development of new business relationships with a specific emphasis on collaborating with [preclinical and clinical CROs]​”, Advantar Labs said in a statement.

Advantar Labs is already working with other service providers. In September it inked a non-exclusive deal with DavosPharma, a provider of discovery, chemistry, and formulation services, to collaborate on helping biopharma clients.

As well as increasing emphasis on CROs, the site will allow Advantar Labs to grow its headcount and add business with manufacturers of finished products and active pharmaceutical ingredients (APIs).

We anticipate that the new facility will accommodate approximately 70 scientists and support staff. Strategically, this move will allow for continued growth, increased efficiency and overall lower costs for our operations​”, Richard Kenley, CEO of Advantar Labs, said.

The move to the new facility began last Thursday and Advantar Labs expects the new site to open for business on Monday. After completing the move Advantar Labs will have several positions to fill and is encouraging anyone who is interested to attend its open house event in May with their résumé.

Related news

Related products

show more

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 19-Oct-2020 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Liver Disease Capabilities

Liver Disease Capabilities

Q² Solutions | 01-Oct-2020 | Clinical Study

We integrate therapeutic insights, state-of-the-art technologies, best-in-class methods and quality systems to optimize NAFLD & NASH study design,...

CAR-T Cell Therapy

CAR-T Cell Therapy

Q² Solutions | 01-Sep-2020 | Clinical Study

Cell therapy involves the transfer of genetically altered cells into a patient. As a global central laboratory services organization, we provide testing...

Related suppliers

Follow us

Products

View more

Webinars